SPECIFIC INTERFERENCE WITH NUCLEAR ERK1/2 SIGNALING PREVENTS PATHOLOGICAL CARDIAC HYPERTROPHY

被引：0
|
作者：
Ruppert, C. [1 ,2 ]
Deiss, K. [1 ]
Herrmann, S. [2 ,3 ]
Vidal, M. [1 ]
Oezkur, M. [2 ,4 ]
Gorski, A. [2 ,4 ]
Weidemann, F. [2 ,3 ]
Lohse, M. J. [1 ,2 ]
Lorenz, K. [1 ,2 ]
机构：
[1] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany
[2] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany
[3] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany
[4] Univ Hosp Wurzburg, Dept Thorac Cardiac & Thorac Vasc Surg, Wurzburg, Germany
来源：
CARDIOLOGY | 2013年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [31] Artemisinin Attenuates Isoproterenol-induced Cardiac Hypertrophy via the ERK1/2 and p38 MAPK Signaling Pathways
    Song, Renxing
    Xiong, Chunming
    Bai, Juncai
    Bai, Zhenzhou
    Liu, Wei
    CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
  • [32] Prolongation of cardiac allograft survival by inhibition of ERK1/2 signaling in a mouse model
    Wang, Shuang
    Guan, Qiunong
    Diao, Hong
    Lian, Dameng
    Zhong, Robert
    Jevnikar, Anthony M.
    Du, Caigan
    TRANSPLANTATION, 2007, 83 (03) : 323 - 332
  • [33] Cadmium interference with ERK1/2 and AhR signaling without evidence for cross-talk
    Gebrael, C.
    Jumarie, C.
    TOXICOLOGY RESEARCH, 2015, 4 (06) : 1488 - 1497
  • [34] Maf1 ameliorates cardiac hypertrophy by inhibiting RNA polymerase III through ERK1/2
    Sun, Yu
    Chen, Cong
    Xue, Ruicong
    Wang, Yan
    Dong, Bin
    Li, Jiayong
    Chen, Chen
    Jiang, Jingzhou
    Fan, Wendong
    Liang, Zhuomin
    Huang, Hulling
    Fang, Rong
    Dai, Gang
    Yan, Youchen
    Yang, Tiqun
    Li, Xiangxue
    Huang, Zhan-Peng
    Dong, Yugang
    Liu, Chen
    THERANOSTICS, 2019, 9 (24): : 7268 - 7281
  • [35] Cardiomyocyte Hypertrophy induced by Visfatin in H9c2 Embryonic Rat Cardiac Cells via ERK1/2 Signaling Pathway
    Yin, Dongyun
    Wan, Qilin
    Ye, Qunhui
    Deng, Yongzhi
    Lin, Bin
    Wu, Lin
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2019, 15 (04) : 503 - 508
  • [36] AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma
    KJ Schmitz
    H Lang
    J Wohlschlaeger
    GC Sotiropoulos
    H Reis
    KW Schmid
    HA Baba
    World Journal of Gastroenterology, 2007, (48) : 6470 - 6477
  • [37] PTEN regulation of ERK1/2 signaling in cancer
    Chetram, Mahandranauth A.
    Hinton, Cimona V.
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2012, 32 (04) : 190 - 195
  • [38] AKT and ERK1/2 signaling in intrahepatic cholanglocarcinoma
    Schmitz, K. J.
    Lang, H.
    Wohlschlaeger, J.
    Sotiropoulos, G. C.
    Reis, H.
    Schmid, K. W.
    Baba, H. A.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (48) : 6470 - 6477
  • [39] Tripartite motif 32 prevents pathological cardiac hypertrophy
    Chen, Lijuan
    Huang, Jia
    Ji, Yanxiao
    Zhang, Xiaojing
    Wang, Pixiao
    Deng, Keqiong
    Jiang, Xi
    Ma, Genshan
    Li, Hongliang
    CLINICAL SCIENCE, 2016, 130 (10) : 813 - 828
  • [40] The nuclear translocation of ERK1/2 as an anticancer target
    Plotnikov, Alexander
    Flores, Karen
    Maik-Rachline, Galia
    Zehorai, Eldar
    Kapri-Pardes, Einat
    Berti, Denise A.
    Hanoch, Tamar
    Besser, Michal J.
    Seger, Rony
    NATURE COMMUNICATIONS, 2015, 6
12345